Novel piperazinyl pyridazine compounds

The invention relates to novel piperazinyl pyridazine compounds in a formula I or salts thereof, a preparation method thereof and use thereof as nervous inflammation inhibitors in treating or preventing neurodegenerative diseases such as senile dementia, Parkinson's disease, cognitive impairmen...

Full description

Saved in:
Bibliographic Details
Main Authors YANG LING, HU WENHUI, LIAO SHENGRONG, XU HONGJIANG
Format Patent
LanguageChinese
English
Published 05.09.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to novel piperazinyl pyridazine compounds in a formula I or salts thereof, a preparation method thereof and use thereof as nervous inflammation inhibitors in treating or preventing neurodegenerative diseases such as senile dementia, Parkinson's disease, cognitive impairment and the like or treating diseases such as mental disorder, epilepsy, convulsions, stroke and the like.The compounds have the advantages of simple preparation process, readily available raw materials and suitability for industrial large-scale production. In addition, through the verification of in-vitro experiments, the compounds have the effect of inhibiting BV2 from secreting IL-1 beta efficiently, and the effect is superior to that of positive medicaments; and simultaneously, the compound have no inhibiting effect on the secretion of the IL-1 beta by C6, and thus the compounds have high safety.
AbstractList The invention relates to novel piperazinyl pyridazine compounds in a formula I or salts thereof, a preparation method thereof and use thereof as nervous inflammation inhibitors in treating or preventing neurodegenerative diseases such as senile dementia, Parkinson's disease, cognitive impairment and the like or treating diseases such as mental disorder, epilepsy, convulsions, stroke and the like.The compounds have the advantages of simple preparation process, readily available raw materials and suitability for industrial large-scale production. In addition, through the verification of in-vitro experiments, the compounds have the effect of inhibiting BV2 from secreting IL-1 beta efficiently, and the effect is superior to that of positive medicaments; and simultaneously, the compound have no inhibiting effect on the secretion of the IL-1 beta by C6, and thus the compounds have high safety.
Author XU HONGJIANG
LIAO SHENGRONG
HU WENHUI
YANG LING
Author_xml – fullname: YANG LING
– fullname: HU WENHUI
– fullname: LIAO SHENGRONG
– fullname: XU HONGJIANG
BookMark eNrjYmDJy89L5WRQ88svS81RKMgsSC1KrMrMqwSyK4syU0DsVIXk_NyC_NK8lGIeBta0xJziVF4ozc2g5OYa4uyhm1qQH59aXJCYnJqXWhLv7GdoYGhhbmBmaeTkZEyUIgDzVCqJ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN101870692BB
GroupedDBID EVB
ID FETCH-epo_espacenet_CN101870692BB3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:43:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN101870692BB3
Notes Application Number: CN2009131106
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120905&DB=EPODOC&CC=CN&NR=101870692B
ParticipantIDs epo_espacenet_CN101870692BB
PublicationCentury 2000
PublicationDate 20120905
PublicationDateYYYYMMDD 2012-09-05
PublicationDate_xml – month: 09
  year: 2012
  text: 20120905
  day: 05
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies JIANGSU CHIA-TAI TIANQING PHARMACEUTICAL CO., LTD
GUANGZHOU INSTITUTE OF BIOMEDICINE AND HEALTH, CHINESE ACADEMY OF SCIENCES
RelatedCompanies_xml – name: JIANGSU CHIA-TAI TIANQING PHARMACEUTICAL CO., LTD
– name: GUANGZHOU INSTITUTE OF BIOMEDICINE AND HEALTH, CHINESE ACADEMY OF SCIENCES
Score 2.9720292
Snippet The invention relates to novel piperazinyl pyridazine compounds in a formula I or salts thereof, a preparation method thereof and use thereof as nervous...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Novel piperazinyl pyridazine compounds
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120905&DB=EPODOC&locale=&CC=CN&NR=101870692B
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1RS8MwED7mFPVNp6JOpYj0rdh1TUsfitC0ZQjrhkzZ20ibFCviSluV-eu9hM75tLfjApfk4HK55O47gLuMswEnnBssc23DFqlpeNzKjNzkWZoPrEFuymrkceKMnu3HOZl34G1dC6NwQr8VOCJaVIb23qjzutw8YoUqt7K-TwtkLR_imR_qbXQsC0FNooeBH00n4YTqlPo00ZMnXwJTuabjWcEO7MprtMTZj14CWZVS_ncp8RHsTVHaR3MMnZ_XHhzQdee1HuyP2w9vJFvbq09AT5Zf4l0ri1JUEhN6hfSqKrjCh9ZkarjskFSfwm0czejIwAkXf7tb0GSztmB4Bl0M-8U5aMTxHDcXHhECgx6bMYaue5gTi3CTIfMC-lsEXW4d7cOhVJbKlSJX0G2qT3GNzrVJb5RWfgHqlX8d
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFOebTkWdP4pI34pd17T0oQhNW6pu3ZAqexttk-JEXOmqMv96L2FzPu0tXOCSHFyOS-77DuAmZ2mXEca0NLdNzeSZrjnMyLVCZ3lWdI1uoQs08iC2omfzYUzGDXhbYWEkT-i3JEdEj8rR32t5X5frRyxf1lbOb7MpimZ3YeL66jI7FkBQnai-5wajoT-kKqUujdX4yRXEVLZuOYa3Bds2poSCZz948QQqpfwfUsJ92Bmhto_6ABo_r21o0VXntTbsDpYf3jhc-t78ENR49sXflXJa8kpwQi9wvKimTPJDK6I0XHRImh_BdRgkNNJwwcnf6SY0Xu_N6x1DE9N-fgIKsRzLLrhDOMekx0zTFEN3ryAGYXqKwlPobFB0tnH2ClpRMuhP-vfxYwf2hOFk3RQ5h2ZdffILDLR1dikt9AsCO4II
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Novel+piperazinyl+pyridazine+compounds&rft.inventor=YANG+LING&rft.inventor=HU+WENHUI&rft.inventor=LIAO+SHENGRONG&rft.inventor=XU+HONGJIANG&rft.date=2012-09-05&rft.externalDBID=B&rft.externalDocID=CN101870692BB